Multi-institutional phase II study of docetaxel (D) and gemcitabine (G) as front-line treatment of patients (pts) with advanced non-small-cell lung cancer (NSCLC).

被引：0
|
作者：
Amenedo, M
Mel, JR
Casal, J
Rodriguez, MR
Aparicio, LA
Constenla, M
Lopez, R
Almanza, C
Huarte, L
机构：
[1] Ctr Oncol Galicia, La Coruna, Spain
[2] Hosp Xeral Calde, Lugo, Spain
[3] Hosp Meixoeiro, Vigo, Spain
[4] Hosp Santa Maria Madre, Orense, Spain
[5] Hosp Juan Canalejo, La Coruna, Spain
[6] Complejo Hosp Pontevedra, Pontevedra, Spain
[7] CHUS, Santiago De Compostela, Spain
[8] POVISA, Vigo, Spain
[9] Aventis Pharma, Madrid, Spain
来源：
ANNALS OF ONCOLOGY | 2000年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
511P
引用
收藏
页码：112 / 112
页数：1
相关论文
共 50 条
  • [1] Front-line treatment of advanced non-small-cell lung cancer with docetaxel and gemcitabine: A multicenter phase II trial
    Georgoulias, V
    Kouroussis, C
    Androulakis, N
    Kakolyris, S
    Dimopoulos, MA
    Papadakis, E
    Bouros, D
    Apostolopoulou, F
    Papadimitriou, C
    Agelidou, A
    Hatzakis, K
    Kalbakis, K
    Kotsakis, A
    Vardakis, N
    Vlachonicolis, J
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (03) : 914 - 920
  • [2] A phase II study of docetaxel (D) and gemcitabine (G) as second-line treatment in patients (pts) with advanced non-small cell lung cancer (NSCLC)
    Agelaki, S
    Papadakis, E
    Tsiafaki, X
    Rapti, A
    Toubis, M
    Bania, E
    Kalbakis, K
    Kouroussis, C
    Androulakis, N
    Georgoulias, V
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S256 - S256
  • [3] Front-line treatment of advanced non-small cell lung cancer with docetaxel and Gemcitabine: A multicenter phase II trial
    Georgoulias, V
    Kourousis, C
    Kakolyris, S
    Dimopoulos, MA
    Papadakis, E
    Apostolopulou, F
    Agelidou, A
    Tzianni, V
    Sarra, E
    Vardakis, N
    ANNALS OF ONCOLOGY, 1998, 9 : 94 - 94
  • [4] Multi-institutional phase II study of carboplatin-gemcitabine combination chemotherapy in elderly patients (pts) with advanced non-small cell lung cancer (NSCLC)
    Sasaki, J.
    Uramoto, H.
    Kashiwabara, K.
    Kishi, H.
    Moriyam, E.
    Ushijima, S.
    Fujii, S.
    Senba, H.
    Okamoto, I.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [5] Phase II study of gemcitabine (G) in combination with docetaxel (D) in advanced non-small-cell lung cancer (NSCLC) patients.: (Oncopaz and Hospitals Associated).
    García, C
    Milla, A
    Feliu, J
    Lorenzo, A
    Madroñal, C
    Gili, F
    Baena, JM
    ANNALS OF ONCOLOGY, 2000, 11 : 113 - 113
  • [6] Phase II trial of gemcitabine, docetaxel, and cetuximab in advanced non-small-cell lung cancer (NSCLC)
    Rubinsak, J. R.
    Spigel, D. R.
    Hainsworth, J. D.
    Webb, C.
    Inhorn, R. C.
    Infante, J. R.
    Yardley, D. A.
    Burris, H. A., III
    Vazquez, E. R.
    Greco, F. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [7] Front-line treatment of advanced non-small cell lung cancer with irinotecan and docetaxel: A multicentre phase II study
    Ziotopoulos, P
    Androulakis, N
    Mylonaki, E
    Chandrinos, V
    Zachariadis, E
    Boukovinas, I
    Agelidou, A
    Kentepozidis, N
    Ignatiadis, M
    Vossos, A
    Georgoulias, V
    LUNG CANCER, 2005, 50 (01) : 115 - 122
  • [8] CARBOPLATIN-DOCETAXEL-BEVACIZUMAB (BVZ) AS FRONT-LINE TREATMENT IN PATIENTS (PTS) WITH STAGE IV NOSQUAMOUS NON SMALL CELL LUNG CANCER (NSCLC). A PHASE II STUDY
    Domine, Manuel
    Antonio Lopez-VilariNo, Jose
    Fuentes, Raquel
    Serrano, Gloria
    Carames, Cristina
    Rubio, Gustavo
    Ignacio Martin-Valades, Jose
    Izarzugaza, Yann
    Luis Arranz, Juan
    Casado, Victoria
    Leon, Ana
    Lobo, Francisco
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1261 - S1261
  • [9] A phase II study of oxaliplatin and docetaxel in patients with advanced non-small-cell lung cancer (NSCLC)
    Raez, L
    Santos, E
    Rocha-Lima, C
    Roman, E
    Kumar, P
    Farfan, N
    Decesare, T
    Lopes, G
    Rosado, M
    Wu, J
    LUNG CANCER, 2005, 49 : S265 - S265
  • [10] Preliminary results of a phase II trial of Docetaxel (D) and Gemcitabine (G) in advanced Non-Small Cell Lung Cancer (NSCLC) in elderly and/or unfit patients (PTS)
    Buffoni, Lucio
    Grillo, Raffaella
    Barone, Carla
    Dongiovanni, Diego
    Gaspari, Fabio
    Giacobino, Alice
    Consito, Lorena
    Ciuffreda, Libero
    Schena, Marina
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S668 - S668
12345